Search Results - Pierre Fenaux

Refine Results
  1. 1

    Personalized medicine in myelodysplastic syndromes: wishful thinking or already clinical reality? by Uwe Platzbecker, Pierre Fenaux

    Published in Haematologica (2015-05-01)
    Get full text
    Article


  2. 2

    Recent frustration and innovation in myelodysplastic syndrome by Uwe Platzbecker, Pierre Fenaux

    Published in Haematologica (2016-08-01)
    Get full text
    Article


  3. 3

    REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE by Emmanuel Gyan, François Dreyfus, Pierre Fenaux

    Get full text
    Article


  4. 4

    TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Lionel Ades, Charicleia Kelaidi, Pierre Fenaux

    Get full text
    Article


  5. 5

    TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH HIGH WHITE CELL BLOOD COUNTS. by Charicleia Kelaidi, Lionel Ades, Pierre Fenaux

    Get full text
    Article


  6. 6

    Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system by Thomas Prebet, Pierre Fenaux, Norbert Vey

    Published in Haematologica (2016-10-01)
    Get full text
    Article


  7. 7

    Infections in myelodysplastic syndromes by Andréa Toma, Pierre Fenaux, François Dreyfus, Catherine Cordonnier

    Published in Haematologica (2012-10-01)
    Get full text
    Article


  8. 8

    TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia by Ramy Rahmé, Thorsten Braun, James J. Manfredi, Pierre Fenaux

    Published in Biomedicines (2023-04-01)
    Get full text
    Article


  9. 9

    Unusual clonal evolution involving 5q in a case of myelodysplastic syndrome with deletion 5q 31 treated with lenalidomide by Virginie Eclache, Anna Da Rocha, Génevieve Le Roux, Pierre Fenaux

    Published in Haematologica (2008-02-01)
    Get full text
    Article


  10. 10

    Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure by Thomas Prébet, Sylvain Thepot, Steven D. Gore, François Dreyfus, Pierre Fenaux, Norbert Vey

    Published in Haematologica (2013-02-01)
    Get full text
    Article


  11. 11

    Inflammatory and Immune Disorders Associated with Myelodysplastic Syndromes by Vincent Jachiet, Pierre Fenaux, Anna Sevoyan, Yervand Hakobyan, Lionel Ades, Olivier Fain, Arsène Mekinian, on behalf of the MINHEMON and GFM

    Published in Hemato (2021-05-01)
    Get full text
    Article


  12. 12

    Cytogenetic follow-up by karyotyping and fluorescence in situ hybridization: implications for monitoring patients with myelodysplastic syndrome and deletion 5q treated with lenalid... by Gudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, Winfried Hofmann, Hans Heinrich Kreipe, Pierre Fenaux, Eva Hellström-Lindberg, Brigitte Schlegelberger

    Published in Haematologica (2011-02-01)
    Get full text
    Article


  13. 13

    Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease by Marie-Camille Lafargue, Mickaël Bobot, Helmut G. Rennke, Marie Essig, Martin Carre, Lucile Mercadal, Jonathan Farhi, Hamza Sakhi, Thibault Comont, Léonard Golbin, Pierre Isnard, Jonathan Chemouny, Nathalie Cambier, Kamel Laribi, Umut Selamet, Leonardo V. Riella, Olivier Fain, Lionel Adès, Pierre Fenaux, Camille Cohen, Arsène Mekinian, Marie-Camille Lafargue, Mickaël Bobot, Thibault Comont, Nathalie Cambier, Kamel Laribi, Olivier Fain, Lionel Adès, Pierre Fenaux, Arsène Mekinian, Thibault Comont, Nathalie Cambier, Kamel Laribi, Olivier Fain, Lionel Adès, Pierre Fenaux, Arsène Mekinian, Thibault Comont, Olivier Fain, Lionel Adès, Pierre Fenaux, Arsène Mekinian

    Published in Kidney International Reports (2023-12-01)
    Get full text
    Article


  14. 14

    Slow relapse in acute myeloid leukemia with inv(16) or t(16;16) by Thomas Clozel, Aline Renneville, Marion Venot, Claude Gardin, Charikleia Kelaidi, Geneviève Leroux, Virginie Eclache, Claude Preudhomme, Pierre Fenaux, Lionel Adès

    Published in Haematologica (2009-10-01)
    Get full text
    Article


  15. 15

    A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe... by Lionel Ades, Agnès Guerci-Bresler, Pascale Cony-Makhoul, Laurence Legros, Marie Sebert, Thorsten Braun, Jacques Delaunay, Kristell Desseaux, Sylvie Chevret, Pierre Fenaux

    Published in Haematologica (2019-04-01)
    Get full text
    Article


  16. 16

    Activation of cytotoxic T-cell receptor γδ T lymphocytes in response to specific stimulation in myelodysplastic syndromes by Jean-Jacques Kiladjian, Géraldine Visentin, Emilie Viey, Sylvie Chevret, Virginie Eclache, Jerome Stirnemann, Jean Henri Bourhis, Salem Chouaib, Pierre Fenaux, Anne Caignard

    Published in Haematologica (2008-03-01)
    Get full text
    Article


  17. 17

    Neurological disorders in essential thrombocythemia by Segolene Billot, Eirini G. Kouroupi, Johan Le Guilloux, Bruno Cassinat, Caroline Jardin, Thierry Laperche, Pierre Fenaux, Antoine F. Carpentier, Jean-Jacques Kiladjian

    Published in Haematologica (2011-12-01)
    Get full text
    Article


  18. 18

    Impact of post-remission therapy in patients aged 65–70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclu... by Raphael Itzykson, Claude Gardin, Cécile Pautas, Xavier Thomas, Pascal Turlure, Emmanuel Raffoux, Christine Terré, Pierre Fenaux, Sylvie Castaigne, Hervé Dombret, Nicolas Boissel

    Published in Haematologica (2011-06-01)
    Get full text
    Article


  19. 19

    Arsenic Trioxide Treatment during Pregnancy for Acute Promyelocytic Leukemia in a 22-Year-Old Woman by Claire Cochet, Marion Simonet, Julie Cattin, Jean-Patrick Metz, Ana Berceanu, Eric Deconinck, Etienne Daguindau, Françoise Schillinger, Pierre Fenaux, Nicolas Mottet, Yohan Desbrosses

    Published in Case Reports in Hematology (2020-01-01)
    Get full text
    Article


  20. 20

    PB2014: A PHASE 2/3 TRIAL OF ORAL AZACITIDINE IN PATIENTS WITH LOW- OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROMES by Guillermo Garcia-Manero, Valeria Santini, Pierre Fenaux, Takahiro Suzuki, Mikkael Sekeres, Jun He, Ronit Barkalifa, Carlos Vigil, Thomas Prebet, Rami S. Komrokji, Aristoteles Giagounidis

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


Search Tools: